Leor Lab

Nili Naftali-Shani PhD Researcher

 

E-mail: nili.naftali@gmail.com 

Phone: +972-3-530-8410

 

Nili is a PhD researcher. Her research is focused on the therapeutic potential of human mesenchymal stem cells (MSCs) for cardiovascular repair.

Publications

​

1. Naftali-Shani N, Levin-Kotler LP, Palevski D, Amit U, Kain D, Landa N, Hochhauser E, Leor J. Left Ventricular Dysfunction Switches Mesenchymal Stromal Cells Toward an Inflammatory Phenotype and Impairs Their Reparative Properties Via Toll-Like Receptor-4. Circulation. 2017 Jun 6;135(23):2271-2287. doi: 10.1161/CIRCULATIONAHA.116.023527. Epub 2017 Mar 29.

​

1. Naftali-Shani N., Itzhaki-Alfia, A., Landa-Rouben, N., Kain, D., Holbova, R., Adutler-Lieber, S., Molotski, N., Asher, E., Grupper, A., Millet, E., Tessone, A., Winkler, E., Kastrup, Jens, Feinberg, Micha S., Zipori D., Pevsner-Fischer M., Raanani, Ehud, and Leor, J. The Origin of Human Mesenchymal Stromal cells Dictates Their Reparative Properties. J Am Heart Assoc. 2013; 2(5):e000253.

 

2. Adutler-Lieber S., Ben-Mordechai T., Naftali-Shani N, Asher E., Loberman D., Raanani E. and Leor J. Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells. J Cardiovasc Pharmacol Ther. 2013; 18(1):78-86. 3. Mayorek, N., Naftali-Shani N., and Grunewald M., Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity. PLoS One. 5(9): p. e12715.